These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 29851751

  • 1. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
    Saito T, Nakai Y, Isayama H, Hirano K, Ishigaki K, Hakuta R, Takeda T, Saito K, Umefune G, Akiyama D, Watanabe T, Takagi K, Takahara N, Hamada T, Uchino R, Mizuno S, Mouri D, Yagioka H, Kogure H, Togawa O, Matsubara S, Ito Y, Yamamoto N, Tada M, Koike K.
    Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
    [Abstract] [Full Text] [Related]

  • 2. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study.
    Saito T, Hirano K, Isayama H, Nakai Y, Saito K, Umefune G, Akiyama D, Watanabe T, Takagi K, Hamada T, Takahara N, Uchino R, Mizuno S, Kogure H, Matsubara S, Yamamoto N, Tada M, Koike K.
    Pancreas; 2017 Mar; 46(3):341-346. PubMed ID: 28099252
    [Abstract] [Full Text] [Related]

  • 3. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE, Nieto-Garcia L, López-Díaz J, Lariño-Noia J, Abdulkader I, Iglesias-Garcia J.
    BMC Cancer; 2018 May 05; 18(1):534. PubMed ID: 29728096
    [Abstract] [Full Text] [Related]

  • 4. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G.
    J Pediatr Gastroenterol Nutr; 2011 Jul 05; 53(1):61-4. PubMed ID: 21694537
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR, McNamara J, Royall J, Caras S, Forssmann K.
    Clin Drug Investig; 2010 Jul 05; 30(6):351-64. PubMed ID: 20441244
    [Abstract] [Full Text] [Related]

  • 6. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N, Malecka-Panas E, Lehman GA, Vasileva G, Shen Y, Sander-Struckmeier S, Caras S, Whitcomb DC.
    Aliment Pharmacol Ther; 2011 May 05; 33(10):1152-61. PubMed ID: 21418260
    [Abstract] [Full Text] [Related]

  • 7. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA, Westermann A, Hoos W, Moravek C, Matrisian L, Wang H, Shemanski L, Barkin JS, Rahib L.
    Pancreas; 2019 Jul 05; 48(6):780-786. PubMed ID: 31210656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct 05; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

  • 10. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ, Gelrud A, Munck A, Caras S.
    Adv Ther; 2010 Dec 05; 27(12):895-916. PubMed ID: 21086085
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
    Woo SM, Joo J, Kim SY, Park SJ, Han SS, Kim TH, Koh YH, Chung SH, Kim YH, Moon H, Hong EK, Lee WJ.
    Pancreatology; 2016 Dec 05; 16(6):1099-1105. PubMed ID: 27618657
    [Abstract] [Full Text] [Related]

  • 12. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
    Barkin JA, Barkin JS.
    Pancreas; 2021 Feb 01; 50(2):176-182. PubMed ID: 33560089
    [Abstract] [Full Text] [Related]

  • 13. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR, Macharg FM, Lawn AM, Preston SR.
    Dis Esophagus; 2013 Aug 01; 26(6):594-7. PubMed ID: 23199208
    [Abstract] [Full Text] [Related]

  • 14. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
    Roberts KJ, Schrem H, Hodson J, Angelico R, Dasari BVM, Coldham CA, Marudanayagam R, Sutcliffe RP, Muiesan P, Isaac J, Mirza DF.
    HPB (Oxford); 2017 Oct 01; 19(10):859-867. PubMed ID: 28711377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP.
    Pancreas; 2016 Oct 01; 45(5):679-86. PubMed ID: 26495784
    [Abstract] [Full Text] [Related]

  • 17. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ, Bannister CA, Schrem H.
    Pancreatology; 2019 Jan 01; 19(1):114-121. PubMed ID: 30385188
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial.
    Catarci M, Berlanda M, Grassi GB, Masedu F, Guadagni S.
    Gastric Cancer; 2018 May 01; 21(3):542-551. PubMed ID: 28804801
    [Abstract] [Full Text] [Related]

  • 19. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK, Vilsbøll T, Lund A, Krarup T, Holst JJ, Hornum M.
    JOP; 2010 Sep 06; 11(5):489-91. PubMed ID: 20818126
    [No Abstract] [Full Text] [Related]

  • 20. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug 06; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.